Canada
· Delayed Price · Currency is CAD Andlauer Healthcare Group Statistics
Total Valuation
Andlauer Healthcare Group has a market cap or net worth of CAD 1.58 billion. The enterprise value is 1.63 billion.
| Market Cap | 1.58B |
| Enterprise Value | 1.63B |
Important Dates
The next estimated earnings date is Wednesday, July 31, 2024.
| Earnings Date | Jul 31, 2024 |
| Ex-Dividend Date | Jun 28, 2024 |
Share Statistics
Andlauer Healthcare Group has 39.51 million shares outstanding. The number of shares has decreased by -0.71% in one year.
| Shares Outstanding | 39.51M |
| Shares Change (YoY) | -0.71% |
| Shares Change (QoQ) | -0.17% |
| Owned by Insiders (%) | 1.53% |
| Owned by Institutions (%) | 29.03% |
| Float | 18.00M |
Valuation Ratios
The trailing PE ratio is 26.41 and the forward PE ratio is 22.59.
| PE Ratio | 26.41 |
| Forward PE | 22.59 |
| PS Ratio | 2.58 |
| PB Ratio | 3.43 |
| P/FCF Ratio | 18.13 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.54, with an EV/FCF ratio of 18.78.
| EV / Earnings | 25.30 |
| EV / Sales | 2.53 |
| EV / EBITDA | 10.54 |
| EV / EBIT | 17.44 |
| EV / FCF | 18.78 |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 26.06.
| Current Ratio | 1.94 |
| Quick Ratio | 1.82 |
| Debt / Equity | 26.06 |
| Debt / EBITDA | 0.81 |
| Debt / FCF | 1.44 |
| Interest Coverage | 11.92 |
Financial Efficiency
Return on equity (ROE) is 13.82% and return on invested capital (ROIC) is 9.60%.
| Return on Equity (ROE) | 13.82% |
| Return on Assets (ROA) | 8.33% |
| Return on Capital (ROIC) | 9.60% |
| Revenue Per Employee | 281,361 |
| Profits Per Employee | 28,181 |
| Employee Count | 2,290 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 96.56 |
Taxes
In the past 12 months, Andlauer Healthcare Group has paid 24.07 million in taxes.
| Income Tax | 24.07M |
| Effective Tax Rate | 27.16% |
Stock Price Statistics
The stock price has decreased by -10.30% in the last 52 weeks. The beta is 0.66, so Andlauer Healthcare Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -10.30% |
| 50-Day Moving Average | 38.76 |
| 200-Day Moving Average | 40.03 |
| Relative Strength Index (RSI) | 60.67 |
| Average Volume (20 Days) | 56,086 |
Short Selling Information
The latest short interest is 169,318, so 0.91% of the outstanding shares have been sold short.
| Short Interest | 169,318 |
| Short Previous Month | 126,152 |
| Short % of Shares Out | 0.91% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Andlauer Healthcare Group had revenue of CAD 644.32 million and earned 64.54 million in profits. Earnings per share was 1.51.
| Revenue | 644.32M |
| Gross Profit | 214.47M |
| Operating Income | 93.61M |
| Pretax Income | 88.60M |
| Net Income | 64.54M |
| EBITDA | 120.50M |
| EBIT | 93.61M |
| Earnings Per Share (EPS) | 1.51 |
Balance Sheet
The company has 68.16 million in cash and 125.11 million in debt, giving a net cash position of -56.95 million or -1.44 per share.
| Cash & Cash Equivalents | 68.16M |
| Total Debt | 125.11M |
| Net Cash | -56.95M |
| Net Cash Per Share | -1.44 |
| Equity (Book Value) | 480.03M |
| Book Value Per Share | 11.62 |
| Working Capital | 87.65M |
Cash Flow
In the last 12 months, operating cash flow was 113.22 million and capital expenditures -26.29 million, giving a free cash flow of 86.93 million.
| Operating Cash Flow | 113.22M |
| Capital Expenditures | -26.29M |
| Free Cash Flow | 86.93M |
| FCF Per Share | 2.20 |
Margins
Gross margin is 33.29%, with operating and profit margins of 14.53% and 10.02%.
| Gross Margin | 33.29% |
| Operating Margin | 14.53% |
| Pretax Margin | 13.75% |
| Profit Margin | 10.02% |
| EBITDA Margin | 18.70% |
| EBIT Margin | 14.53% |
| FCF Margin | 13.49% |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 1.00%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 1.00% |
| Dividend Growth (YoY) | 26.67% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 23.21% |
| Buyback Yield | 0.71% |
| Shareholder Yield | 1.71% |
| Earnings Yield | 3.79% |
| FCF Yield | 5.52% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |